Provided by Tiger Fintech (Singapore) Pte. Ltd.

Schrodinger Inc.

21.05
+0.17000.81%
Post-market: 21.150.1000+0.48%19:42 EDT
Volume:1.17M
Turnover:24.68M
Market Cap:1.54B
PE:-7.98
High:21.62
Open:20.86
Low:20.49
Close:20.88
Loading ...

Schrodinger Inc Outlook Q1 2025, Software Revenue Expected to Range From $44 Mln to $48 Mln.

THOMSON REUTERS
·
27 Feb

Schrodinger Inc Outlook FY Software Revenue Growth Expected to Range From 10% to 15%.

THOMSON REUTERS
·
27 Feb

Schrodinger (SDGR) Receives a Buy from Craig-Hallum

TIPRANKS
·
24 Feb

Schrödinger to Participate in Upcoming Investor Conferences

Business Wire
·
24 Feb

Why Xpeng (XPEV) and Schrodinger (SDGR) Are Advancing Today

Insider Monkey
·
19 Feb

Schrodinger Stock Scores IBD Rating Upgrade

Blockhead
·
15 Feb

Press Release: Schrödinger to Announce Fourth Quarter and Full-Year 2024 Financial Results on February 26

Dow Jones
·
12 Feb

Craig-Hallum Reaffirms Their Buy Rating on Schrodinger (SDGR)

TIPRANKS
·
31 Jan

Strong week for Schrödinger (NASDAQ:SDGR) shareholders doesn't alleviate pain of five-year loss

Simply Wall St.
·
31 Jan

Schrödinger (SDGR): Revolutionizing Biopharma with Quantum Mechanics and AI

Insider Monkey
·
30 Jan

Market Participants Recognise Schrödinger, Inc.'s (NASDAQ:SDGR) Revenues Pushing Shares 25% Higher

Simply Wall St.
·
25 Jan

Schrodinger Is Maintained at Overweight by Keybanc

Dow Jones
·
25 Jan

Schrödinger, Inc. (SDGR): Quantum Mechanics Meets AI in Biopharma, Backed by Hunterbrook’s ‘Key AI Winner’ Endorsement

Insider Monkey
·
25 Jan

Why Schrödinger, Inc. (SDGR) Is Skyrocketing Now

Insider Monkey
·
24 Jan

Morgan Stanley Reaffirms Their Hold Rating on Schrodinger (SDGR)

TIPRANKS
·
23 Jan

Hunterbrook Capital long ‘key AI winner’ Schrodinger

TIPRANKS
·
23 Jan

Why Drug Developers That Utilize AI, Including SDGR and RXRX, Are Jumping

Insider Monkey
·
23 Jan

SchrÖDinger Reports Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)

THOMSON REUTERS
·
22 Jan

Schrödinger Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)

Business Wire
·
22 Jan

Conviction stock-picking drives biotech success: a biotech market review of 2024

LiveWire
·
17 Jan